1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Mobility Limitation: new trials by email Literature Review of Mobility Limitation trials Research Report on Mobility Limitation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease Adrabetadex - Niemann-Pick Disease, Type C | Phase 2 / Phase 3 | Terminated | Mandos LLC | 66 | 2015-12-23 | 2023-08-29 |
Cognitive Dysfunction (1) · Deglutition Disorders (1) · Disease (1) · Niemann-Pick Disease, Type C (1)
Brain Diseases (1) · Brain Diseases, Metabolic (1) · Brain Diseases, Metabolic, Inborn (1) · Central Nervous System Diseases (1) · Cognition Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Esophageal Diseases (1) · Gastrointestinal Diseases (1) · Genetic Diseases, Inborn (1) · Hemic and Lymphatic Diseases (1) · Histiocytosis (1) · Histiocytosis, Non-Langerhans-Cell (1) · Lipid Metabolism Disorders (1) · Lipid Metabolism, Inborn Errors (1)
2-Hydroxypropyl-beta-cyclodextrin (1) · Cyclodextrins (1)
Mandos LLC (1)
Australia (1) · France (1) · Germany (1) · New Zealand (1) · Singapore (1) · Switzerland (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)
2015 (1)